Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 5027-5032, December 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henry, C. J.
Right arrow Articles by Kouri, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henry, C. J.
Right arrow Articles by Kouri, R. E.

Lung Cancer Model System Using 3-Methylcholanthrene in Inbred Strains of Mice1

C. J. Henry2, L. H. Billups3, M. D. Avery, T. H. Rude, D. R. Dansie, A. Lopez, B. Sass4, C. E. Whitmire5 and R. E. Kouri

Departments of Experimental Oncology [C. J. H., L. H. B., M. D. A., D. R. D., A. L., B. S., C. E. W.] and Biochemical Oncology [T. H. R., R. E. K.], Microbiological Associates, Bethesda, Maryland 20816

A model system has been established for studying lung carcinogenesis using intratracheal instillation of 3-methylcholanthrene in C3H / AnfCum and C57BL / Cum x C3H/AnfCum F1 (hereafter called BC3F1/Cum) mice. The animals in these studies were screened for adventitious agents and were free throughout their lifetime of two important lung viruses, Sendai virus and pneumonia virus of mice. Under these conditions, the occurrence of spontaneous and chemically induced lung cancers was determined over the lifetime of the animals. Data were analyzed by the actuarial method for lung tumor probability. Probability was found to be dose and time dependent. Over 95% of the 3-methylcholanthrene-treated BC3F1/Cum and over 88% of the C3H/AnfCum mice were found at death to have pulmonary carcinomas. Tumors observed in animals which died up to 40 weeks on test were almost always squamous cell carcinomas (~85%), while tumors which were observed in animals which died after 50 weeks were mainly alveolar adenocarcinomas (~80%). Both tumor types metastasized widely. Spontaneous lung cancers (only alveolar adenocarcinomas were observed) occurred in these two strains at low frequency and were expressed late in life. Thus, the system described affords a suitable model to study the induction, expression, and progression of lung tumors under conditions where a vast majority of animals develop neoplasia.

1 Supported in part by contracts from The Council for Tobacoo Research—U. S. A., Inc. Presented in part at the 70th Annual Meeting of the American Association for Cancer Research, Inc., New Orleans, La., May 16 to 19, 1979 (3).

2 To whom requests for reprints should be addressed.

3 Present address: Environmental Pathology Services, Rockville Medical Center, 809 Veirs Mill Road, Rockville, Md. 20851.

4 Present address: Registry of Experimental Cancers, Division of Cancer Cause and Prevention, National Cancer Institute, Bethesda, Md. 20205.

5 Present address: National Cancer Institute-National Toxicology Program, Landow Building, Bethesda, Md. 20205.

Received 5/28/81. Accepted 9/16/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.